A novel adenosine analog, AMP579, inhibits neutrophil activation, adherence and neutrophil-mediated injury to coronary vascular endothelium

By Nakamura M.   Zhao Z.-Q.   Clark K.L.   Velez D.V.   Guyton R.A.   Vinten-Johansen J.  

European Journal of Pharmacology, Vol. 397, Iss. 1, 2000-05 ,pp. : 197-205

Elsevier

Access to resources Recommend Favorite

Mechanisms of Neutrophil-mediated Disease: Innovative Therapeutic Interventions

By  

Current Pharmaceutical Design, Vol. 18, Iss. 12, 2012-04 ,pp. : 1609-1619

Bentham Science Publishers

Access to resources Recommend Favorite

The role of ADP in endotoxin-induced equine platelet activation

By Jarvis G.E.   Evans R.J.   Heath M.F.  

European Journal of Pharmacology, Vol. 315, Iss. 2, 1996-11 ,pp. : 203-212

Elsevier

Access to resources Recommend Favorite

Neutrophil Derived Microvesicles: Emerging Role of a Key Mediator to the Immune Response

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 14, Iss. 3, 2014-09 ,pp. : 210-217

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of P-selectin attenuates neutrophil-mediated myocardial dysfunction in isolated rat heart

By Ohnishi M.   Yamada K.   Morooka S.   Tojo S.J.  

European Journal of Pharmacology, Vol. 366, Iss. 2, 1999-02 ,pp. : 271-279

Elsevier

Access to resources Recommend Favorite